196 related articles for article (PubMed ID: 25501833)
1. A loss of FUS/TLS function leads to impaired cellular proliferation.
Ward CL; Boggio KJ; Johnson BN; Boyd JB; Douthwright S; Shaffer SA; Landers JE; Glicksman MA; Bosco DA
Cell Death Dis; 2014 Dec; 5(12):e1572. PubMed ID: 25501833
[TBL] [Abstract][Full Text] [Related]
2. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein.
Yang S; Warraich ST; Nicholson GA; Blair IP
Int J Biochem Cell Biol; 2010 Sep; 42(9):1408-11. PubMed ID: 20541619
[TBL] [Abstract][Full Text] [Related]
3. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
[TBL] [Abstract][Full Text] [Related]
4. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma.
Patil N; Ahmed Kabeer Rasheed S; Abba M; Hendrik Leupold J; Schwarzbach M; Allgayer H
Int J Cancer; 2014 Jun; 134(12):2808-19. PubMed ID: 24285420
[TBL] [Abstract][Full Text] [Related]
5. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
6. Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.
Göransson M; Elias E; Ståhlberg A; Olofsson A; Andersson C; Aman P
Int J Cancer; 2005 Jul; 115(4):556-60. PubMed ID: 15688424
[TBL] [Abstract][Full Text] [Related]
7. FUS/ERG gene fusions in Ewing's tumors.
Shing DC; McMullan DJ; Roberts P; Smith K; Chin SF; Nicholson J; Tillman RM; Ramani P; Cullinane C; Coleman N
Cancer Res; 2003 Aug; 63(15):4568-76. PubMed ID: 12907633
[TBL] [Abstract][Full Text] [Related]
8. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
Wang XN; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
[TBL] [Abstract][Full Text] [Related]
9. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.
Armstrong GA; Drapeau P
Hum Mol Genet; 2013 Nov; 22(21):4282-92. PubMed ID: 23771027
[TBL] [Abstract][Full Text] [Related]
10. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
11. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation.
Ichikawa H; Shimizu K; Hayashi Y; Ohki M
Cancer Res; 1994 Jun; 54(11):2865-8. PubMed ID: 8187069
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
13. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.
Morohoshi F; Arai K; Takahashi EI; Tanigami A; Ohki M
Genomics; 1996 Nov; 38(1):51-7. PubMed ID: 8954779
[TBL] [Abstract][Full Text] [Related]
14. FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis.
Kino Y; Washizu C; Kurosawa M; Yamada M; Miyazaki H; Akagi T; Hashikawa T; Doi H; Takumi T; Hicks GG; Hattori N; Shimogori T; Nukina N
Acta Neuropathol Commun; 2015 Apr; 3():24. PubMed ID: 25907258
[TBL] [Abstract][Full Text] [Related]
15. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky HA; Hu M; Hickstein DD; Yang L
Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.
Sato S; Idogawa M; Honda K; Fujii G; Kawashima H; Takekuma K; Hoshika A; Hirohashi S; Yamada T
Gastroenterology; 2005 Oct; 129(4):1225-36. PubMed ID: 16230076
[TBL] [Abstract][Full Text] [Related]
18. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
19. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins.
Guipaud O; Guillonneau F; Labas V; Praseuth D; Rossier J; Lopez B; Bertrand P
Proteomics; 2006 Nov; 6(22):5962-72. PubMed ID: 17106916
[TBL] [Abstract][Full Text] [Related]
20. FUS regulates the alternative splicing of cell proliferation genes related to atherosclerosis.
Hou J; Yang S; Guo Y; Yan N; Jia S
Exp Biol Med (Maywood); 2023 Sep; 248(17):1459-1468. PubMed ID: 37688506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
